Purecycle Technologies Stock Earnings Reports

Key investor points from PureCycle Q1 2026 corporate update:

- Operations and production: Ironton produced 8.4 million pounds of PureFive in Q1 (up ~12% vs Q4) with ~10 million pounds of feedstock processed. A planned turnaround was completed ahead of schedule and ~15% below budget; over 170 improvement projects were executed to boost capacity, reliability and quality. On-site compounding reached mechanical completion in April and is being commissioned; third-party compounding volume ~1.7 million pounds for Q1 with strong month-over-month growth.

- Commercial progress: Q1 revenue was $4.1 million (fifth consecutive quarter of sequential growth) with an increasing branded sales mix. Pipeline ~180 active opportunities (vs ~100 a year ago). Procter & Gamble commercial approvals achieved for two applications (Tide caps shipping in Q2; Vicks ZzzQuil caps later in 2026). Coffee/hot lids (Plastic Ingenuity) and other branded conversions are ramping; first international sale in Q1 (~300k+ lbs).

- Market & regulatory tailwinds: Elevated virgin polypropylene and HDPE prices are improving PureCycle’s competitive and co-product economics. Regulatory drivers include California SB 54 source reduction mandates and New Jersey increasing PCR requirements (food-contact exemption sunset early 2027) — both create urgency for compliant food-grade recycled PP where PureCycle is positioned as a scaled supplier with APR certification.

- Financial & capital position: Q1 net loss $33.4M; adjusted EBITDA negative $30.9M (includes ~$7M of project development costs expensed). Operational KPIs disclosed showing emerging operating leverage (production up ~95% YoY while monthly ops spend rose only ~6%). Total liquidity ~ $131M (cash $90M + marketable securities ~$31M + restricted cash $10M), down from ~$182M at year-end. Warrants extended to March 17, 2027 (total potential proceeds ~$273M); $200M revolver undrawn; ~$75M revenue bonds available. FY2026 project spend guidance unchanged at $39M–$45M.

- Growth projects & timeline: Thailand facility on track for mechanical completion by end of 2027 and commissioning/production in 2028 with estimated capex ~$250M (groundbreak H2 2026). Belgium on track for permits near year-end 2026, construction Q1 2027, mechanical completion end of 2028; capex ~€350M with a EUR 40M European Innovation Fund grant secured. Gen 2 design economics continue to validate.

- Outlook: Management reiterates confidence in the commercial ramp through 2026, with Q3–Q4 expected to show more meaningful volume growth as branded applications scale and regulatory catalysts (notably NJ/CA) drive customer urgency.